MetaCap

Cellectis S.A. (CLLS) News

NASDAQ: CLLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.9209-0.0789 (-7.89%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CLLS news summary

We found 9 recent headlines mentioning Cellectis S.A. (CLLS): 0 in the past week and 9 in the past 30 days, most often from GlobeNewswire, Nasdaq. CLLS is making an outsized move today, down 7.89% at $0.9209, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Cellectis publie ses résultats financiers du troisième trimestre 2026 et une mise à jour de ses activités", was published by GlobeNewswire on Nov 12, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Cellectis S.A. headlines

Compare CLLS